[{"Assets_0_Q3_USD":"57433000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.41","CommonStockDividendsPerShareDeclared_3_Q3_USD":"0.41","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.83","EarningsPerShareBasic_3_Q3_USD":"2.75","EarningsPerShareDiluted_1_Q3_USD":"0.83","EarningsPerShareDiluted_3_Q3_USD":"2.75","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","MinorityInterest_0_Q3_USD":"106000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"6029000000.0","NetIncomeLoss_1_Q3_USD":"1353000000.0","NetIncomeLoss_3_Q3_USD":"4495000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","ProfitLoss_1_Q3_USD":"1366000000.0","ProfitLoss_3_Q3_USD":"4520000000.0","RevenuesConverted_1_Q3_USD":"6007000000.0","RevenuesConverted_3_Q3_USD":"18200000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"17754000000.0","StockholdersEquity_0_Q3_USD":"17648000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1634000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1636000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1632000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1634000000.0","filed":"20191031","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"BRISTOL MYERS SQUIBB CO","period":"20190930","qtrs":"0","uom":"USD"}]